CTLA4 and neoplasm: In contrast, in the majority of cases, sole application of any of the anti-CTLA-4, anti-PD-1, and/or anti-HSP90 molecules used either alone or in combination with each other did not affect the clonogenic potential of the lung-derived tumor cells.